Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
#boosting shares#Roche oral#oral drug#drug shown#breast cancer
Life Science News
Latest updates from the biotech and pharma world
Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer - GenomeWeb
#Cancer Genomics#Genomics Potential#Axelios Sequencer#Sequencer GenomeWeb#GenomeWeb Roche
Obituary information for Kathleen M. Roche - Cartmell Davis Funeral Home
#Davis Funeral#Cartmell Davis#Funeral Home#Roche Cartmell#Obituary information
Ice Bears swap Finstrom for blue liner Roche - Knoxville Ice Bears
#Ice Bears#Knoxville Ice#swap Finstrom#Bears swap#Bears Ice
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
#European Pharmaceutical#Pharmaceutical Review#fenebrutinib shows#Review Roche#Pharmaceutical
Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena
#Phase III#Clinical Trials#Trials Arena#BTK inhibitor#Roche sizes
Artificial Intelligence at Roche Diagnostics - Emerj Artificial Intelligence Research
#Artificial Intelligence#Intelligence Research#Roche Diagnostics#Emerj Artificial#Research Artificial
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
#BTK inhibitor#Fierce Biotech#reports phase#multiple sclerosis#Roche reports
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market - Yahoo Finance
#Yahoo Finance#Market Yahoo#Finance Roche#Unleashed#Drug
Why Roche Holding Stock Popped Today - Yahoo Finance
#Roche Holding#Holding Stock#Stock Popped#Popped Today#Yahoo Finance
Roche's experimental MS drug hits main goal in one of two key trials - Reuters
#Roche experimental#drug hits#hits main#main goal#key trials
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
#BioPharma Dive#tablet scores#Dive Roche#late-stage studies#Dive
Roche Rival Plunges On 'Unprecedented' Results In MS Treatment - Investor's Business Daily
#Rival Plunges#Investor Business#Business Daily#Roche Rival#Treatment Investor
Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena
#Phase III#III trial#Clinical Trials#Trials Arena#SLE meets
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold - BioSpace
#Barrier Tech#Roche Piles#Blood-Brain Barrier#Piles#Manifold BioSpace
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win - Fierce Pharma
#Roche Gazyva#Fierce Pharma#hot streak#autoimmune hot#Pharma Roche
Roche signs $2B pact to pilot Manifold Bio's shuttles to the brain - Fierce Biotech
#Manifold Bio#Fierce Biotech#pilot Manifold#Bio shuttles#Roche signs
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
#Roche taps#BioPharma Dive#Dive Roche#brain drugs#Dive
Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases - Business Wire
#Bio Announces#Announces Strategic#Strategic Collaboration#Develop Multiple#Brain Shuttles
Is Roche a Hidden Gem After Its New Immunotherapy Partnerships and Share Price Dip? - Yahoo Finance
#Price Dip#Hidden Gem#Immunotherapy Partnerships#Share Price#Yahoo Finance